FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979496622> ?p ?o ?g. }

• W2979496622 endingPage "533" @default.
• W2979496622 startingPage "525" @default.
• W2979496622 abstract "Whole pelvis radiation therapy (WPRT) may improve clinical outcomes over prostate-only radiation therapy (PORT) in high-risk prostate cancer patients by sterilization of micrometastatic nodal disease, provided there is optimal control of the primary site.A prospective multicenter cohort study of eligible patients (stage ≥T2c, Gleason score ≥7 or presenting prostate-specific antigen ≥10) treated between 2009 and 2013 were enrolled in a United Kingdom national protocol delivering combined external beam radiation therapy and high-dose-rate brachytherapy. Centers elected to deliver WPRT, 46 Gy in 23 fractions or PORT 37.5 Gy in 15 fractions with 15 Gy single dose high-dose-rate brachytherapy. The primary endpoint was biochemical progression-free survival (bPFS). Secondary endpoints were overall survival, genitourinary, and gastrointestinal toxicity. This was not a randomized comparison and was subject to bias; the findings are therefore hypothesis generating, but not conclusive.Eight hundred and twelve patients were entered; 401 received WPRT and 411 received PORT. With a median follow-up of 4.7 years, 5-year bPFS rates for WPRT versus PORT arms were 89% versus 81% (P = .007) for all patients and 84% versus 77% (P = .001) for high-risk patients. Differences in bPFS remained significant after accounting for Gleason score, presenting prostate-specific antigen, T stage, and androgen deprivation therapy duration as covariates. There was no difference in overall survival. The overall post treatment toxicities across both cohorts were low with no greater than 1.5% of ≥grade 3 toxicities at any follow-up time point. WPRT increased both prevalence and cumulative incidence of acute genitourinary toxicity (P = .004) and acute gastrointestinal toxicity (P = .003). No difference in late radiation toxicity was observed.A significant improvement in 5-year bPFS was seen in intermediate and high-risk prostate cancer treated with WPRT compared with PORT in a combined external beam radiation therapy and brachytherapy schedule with no increase in late radiation toxicity." @default.
• W2979496622 created "2019-10-18" @default.
• W2979496622 creator A5010055502 @default.
• W2979496622 creator A5011539507 @default.
• W2979496622 creator A5020453607 @default.
• W2979496622 creator A5041859071 @default.
• W2979496622 creator A5064462739 @default.
• W2979496622 creator A5067219785 @default.
• W2979496622 creator A5075388907 @default.
• W2979496622 creator A5076810961 @default.
• W2979496622 creator A5089586523 @default.
• W2979496622 date "2020-03-01" @default.
• W2979496622 modified "2023-10-18" @default.
• W2979496622 title "External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume" @default.
• W2979496622 cites W1879241913 @default.
• W2979496622 cites W1967144750 @default.
• W2979496622 cites W1984192990 @default.
• W2979496622 cites W2004423705 @default.
• W2979496622 cites W2004601306 @default.
• W2979496622 cites W2010751529 @default.
• W2979496622 cites W2012580954 @default.
• W2979496622 cites W2039978974 @default.
• W2979496622 cites W2047912614 @default.
• W2979496622 cites W2054899405 @default.
• W2979496622 cites W2062313368 @default.
• W2979496622 cites W2076303343 @default.
• W2979496622 cites W2093867637 @default.
• W2979496622 cites W2097532477 @default.
• W2979496622 cites W2131398800 @default.
• W2979496622 cites W2149659669 @default.
• W2979496622 cites W2163954169 @default.
• W2979496622 cites W2167949509 @default.
• W2979496622 cites W2507208844 @default.
• W2979496622 cites W2531790917 @default.
• W2979496622 cites W2536173378 @default.
• W2979496622 cites W2553678345 @default.
• W2979496622 cites W2598815466 @default.
• W2979496622 cites W2616221802 @default.
• W2979496622 cites W2740762562 @default.
• W2979496622 cites W2749452828 @default.
• W2979496622 cites W2896329607 @default.
• W2979496622 doi "https://doi.org/10.1016/j.ijrobp.2019.09.044" @default.
• W2979496622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31610249" @default.
• W2979496622 hasPublicationYear "2020" @default.
• W2979496622 type Work @default.
• W2979496622 sameAs 2979496622 @default.
• W2979496622 citedByCount "23" @default.
• W2979496622 countsByYear W29794966222020 @default.
• W2979496622 countsByYear W29794966222021 @default.
• W2979496622 countsByYear W29794966222022 @default.
• W2979496622 countsByYear W29794966222023 @default.
• W2979496622 crossrefType "journal-article" @default.
• W2979496622 hasAuthorship W2979496622A5010055502 @default.
• W2979496622 hasAuthorship W2979496622A5011539507 @default.
• W2979496622 hasAuthorship W2979496622A5020453607 @default.
• W2979496622 hasAuthorship W2979496622A5041859071 @default.
• W2979496622 hasAuthorship W2979496622A5064462739 @default.
• W2979496622 hasAuthorship W2979496622A5067219785 @default.
• W2979496622 hasAuthorship W2979496622A5075388907 @default.
• W2979496622 hasAuthorship W2979496622A5076810961 @default.
• W2979496622 hasAuthorship W2979496622A5089586523 @default.
• W2979496622 hasBestOaLocation W29794966222 @default.
• W2979496622 hasConcept C121608353 @default.
• W2979496622 hasConcept C126322002 @default.
• W2979496622 hasConcept C126894567 @default.
• W2979496622 hasConcept C143998085 @default.
• W2979496622 hasConcept C168563851 @default.
• W2979496622 hasConcept C203092338 @default.
• W2979496622 hasConcept C2775908122 @default.
• W2979496622 hasConcept C2776235491 @default.
• W2979496622 hasConcept C2777416452 @default.
• W2979496622 hasConcept C2777899217 @default.
• W2979496622 hasConcept C2780192828 @default.
• W2979496622 hasConcept C2781406297 @default.
• W2979496622 hasConcept C509974204 @default.
• W2979496622 hasConcept C71924100 @default.
• W2979496622 hasConceptScore W2979496622C121608353 @default.
• W2979496622 hasConceptScore W2979496622C126322002 @default.
• W2979496622 hasConceptScore W2979496622C126894567 @default.
• W2979496622 hasConceptScore W2979496622C143998085 @default.
• W2979496622 hasConceptScore W2979496622C168563851 @default.
• W2979496622 hasConceptScore W2979496622C203092338 @default.
• W2979496622 hasConceptScore W2979496622C2775908122 @default.
• W2979496622 hasConceptScore W2979496622C2776235491 @default.
• W2979496622 hasConceptScore W2979496622C2777416452 @default.
• W2979496622 hasConceptScore W2979496622C2777899217 @default.
• W2979496622 hasConceptScore W2979496622C2780192828 @default.
• W2979496622 hasConceptScore W2979496622C2781406297 @default.
• W2979496622 hasConceptScore W2979496622C509974204 @default.
• W2979496622 hasConceptScore W2979496622C71924100 @default.
• W2979496622 hasFunder F4320309603 @default.
• W2979496622 hasFunder F4320320292 @default.
• W2979496622 hasIssue "3" @default.
• W2979496622 hasLocation W29794966221 @default.
• W2979496622 hasLocation W29794966222 @default.
• W2979496622 hasLocation W29794966223 @default.
• W2979496622 hasLocation W29794966224 @default.
• W2979496622 hasLocation W29794966225 @default.

• next